
|Articles|October 1, 2007
Oncology NEWS International
- Oncology NEWS International Vol 16 No 10
- Volume 16
- Issue 10
Merck to donate 3 million doses of Gardasil to poor countries
Merck to donate 3 million doses of Gardasil to poor countries
Advertisement
NEW YORKMerck & Co. has committed to donate at least 3 million doses of it human papillomavirus vaccine Gardasil over the next 5 years for use in demonstration projects in lowest income nations throughout the world. The company made the announcement at the Clinton Global Initiative 2007 meeting. "We are committing to the vaccination of 1 million females against cervical cancer," said Merck's Margaret McGlynn.
Articles in this issue
almost 19 years ago
Bill aims to 'revitalize' FDA by adding powers and databasesalmost 19 years ago
New myeloma trial results; two new studies initiatedalmost 19 years ago
Neoadjuvant trastuzumab increases pCR ratesalmost 19 years ago
Court rejects right of terminally ill to unproven drugsalmost 19 years ago
Sorafenib improves overall survival in Asian HCC ptsalmost 19 years ago
Skipping tam doses increases risk of deathalmost 19 years ago
The SGR: The madness behind physician payment fee cutsalmost 19 years ago
Dr. Pegram seeks new breast cancer challenges at Miamialmost 19 years ago
SearchMedica.com receives awardAdvertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Iza-Bren Yields Encouraging Activity in Extensive-Stage SCLC
2
Sirexatamab Regimen May Improve PFS, OS in DKK1-High Colorectal Cancer
3
Monitoring and Mitigating Emergent Toxicities During CAR T-Cell Therapy
4
Bolstering The Referral Process for CAR T-Cell Therapy in Multiple Myeloma
5




















































